Memorandum Evonik-Joint Venture Establish Production Facility for L-lysine in Russia
Evonik and the government of the Russian Rostov Region reaffirmed their corperation for the production of L-lysine. A corresponding memorandum of understanding was signed. The objective is to establish a facility for the production of feedstuff additive Biolys in Volgodonsk/Russia through the joint venture OOO Donbiotech.
Berlin – The joint venture of Evonik Industries and the Varshavky Group will use the new plant to produce L-lysine. Biolys is considered a source of lysine in animal feed for swine and poultry. The new facility is to become operational in 2014 and will have an annual capacity of 100 000 metric tons. The raw material to be processed by the joint venture will consist of wheat grown in the Rostov Region.
“The new Biolys plant is a windfall for our region and the city of Volgodonsk," said Vasily Golubev, Governor of the Rostov region. "It will create about 200 professional-level jobs and will add value to wheat as a regional resource.“ Patrick Wohlhauser, Member of the Executive Board Evonik, had an equally positive assessment of the joint venture: “This effort secures the raw material supply, while the backwards integration will cover a larger part of the supply chain. That is essential for positioning Evonik in the important Russian market.”
Amino acids for animal feed, and particularly DL-methionine, are part of the core business of Evonik. Additional capacities for Trypamino (L-tryptophan) and Biolys (source of L-lysine) have been established in Europe and the U.S. and the new methionine plant currently under construction in Singapore, which marks the largest chemicals investment of the company to date.
More plant engineering projects can be found in our online-databaseGROAB.